cuments: the company’s 2025 Form 10-K (business model, loan collateral, and funding structure).
Recent Performance
Over the last 12 months, LOAN has materially lagged the broader market. The stock is down roughly the high-teens over 1 year (MarketBeat reports ≈ -18.65% 1-year total return). Over the same window, the S&P 500 put up mid-teens positive 1-year returns (YCharts S&P 1-year ~ +14%–15% in early 2026).
That gap reflects a mix of softer loan originations and interest income in recent quarters, modest top-line growth, and investor nerves about leverage and the timing of funding for a small balance-sheet lender.
In Q1 2026, results showed revenue down and net income slightly lower versus the prior-year quarter. Management has also been active on financing and buyback items, which can signal opportunity — but also highlights financing risk.
Fundamental Analysis
Growth Prospects
Growth has been modest. The latest reported sales growth is ~3.7% (user-provided), and public filings show a relatively stable but small-scale origination engine.
The near-term growth levers are: (1) more loan originations if credit markets normalize, (2) higher utilization of secured lending lines, and (3) selectively moving into new geographies or asset niches if capital is available.
The near-term reality is that origination volumes and net interest income depend heavily on mortgage/real-estate activity, competition from banks and specialty finance lenders, and the availability and cost of funding. Management’s recent commentary and filings point to limited scale and gradual growth, not a rapid expansion plan.
Sources: 2025 Form 10-K and recent quarterly disclosures.
Quality & Moat
Manhattan Bridge is a niche, asset-backed lender, not a “brand moat” business.
Strengths include a high operating margin (~59%), consistent free-cash-flow generation (FCF yield ~12.90% vs a five-year average ~8.12%), and low stock volatility/beta (beta ~0.11), which suggests low correlation with the wider market.
Weak spots are typical for a small lender: limited scale, a concentrated loan book, and the fact that underwriting quality matters a lot because a few loans can move the needle. On capital efficiency, ROIC (~7.99%) sits below the market average (~10.78%), which points to more modest returns on invested capital than larger peers.
Management has returned capital through a modest buyback program and a quarterly dividend — shareholder-friendly if they’re funded from sustainable cash flow.
See the Form 10-K and recent earnings for details on collateral, underwriting, and capital actions.
Valuation
On the surface, the stock looks cheap. LOAN’s forward P/E is ~9.91 versus a market average near ~25x (user-provided), so investors are paying a meaningful discount to the broader market.
EV/Sales (~8.17) is below the company’s five-year average (~9.09), but above the market EV/Sales (~4.40). That mix can happen with asset-backed lenders: revenues can look “thin” relative to enterprise value, even when interest margins are relatively steady.
The loudest valuation signal is cash generation. LOAN’s FCF yield (~12.9%) is very strong relative to the market (~2.24%).
That discount still has a logic to it: small scale, higher idiosyncratic credit and funding risk, and lower growth. Investors appear to be pricing those risks in.
User ratios used as primary valuation inputs.
Market Sentiment
Sentiment looks cautious-to-neutral.
Analyst coverage is light. The most recent commercial note is a Hold from one boutique shop, and broader institutional coverage is limited. Short interest isn’t big in absolute dollars, but the stock’s low float and small market cap can amplify price moves.
Management has declared a regular quarterly dividend and executed a small buyback, which can provide some support. At the same time, recent SEC filings and press releases show active management of credit facilities and debt instruments — and markets tend to watch those closely for a lender.
Social media mentions and small-cap chatter are muted, and the overall view feels conservative rather than bullish.
Sources: recent press releases, filings, and independent data aggregators.
Key Risks
*Funding and refinancing risk*: The company uses credit lines and notes to fund loan originations. Any disruption to those facilities — or a re-pricing higher — could squeeze margins or force the company to pull back on originations. Recent filings reference amendments and redemptions of secured notes and credit lines, which underlines the sensitivity here.
*Credit / portfolio concentration*: This is a small lender with a concentrated loan book. That means a borrower default or a drop in collateral value can create outsized losses versus more diversified peers. Investors should track underwriting and loss reserves in each 10-Q/10-K.
*Leverage (quantitative)*: Net debt-to-EBITDA is ~3.80 (user-provided), well above the market average (~1.37). That may be manageable for an established finance company, but it increases vulnerability to weaker earnings or higher funding costs. It can also limit flexibility for M&A or larger buybacks.
*Liquidity & interest coverage*: Public disclosures show active management of lines and notes. While interest expense has fallen with lower borrowings in some periods, renewed rate pressure or tighter funding could reduce interest coverage. Investors should watch the next 10-Q for interest expense and coverage metrics.
*Small-cap, low liquidity*: A low float and small market cap can make the stock jumpy on news, even with a low beta. Moves can be sharp on company updates or funding headlines.
Bull Case
*Cheap on cash metrics*: A forward P/E of ~9.9 and an FCF yield of ~12.9% suggest the stock already trades with a meaningful risk discount. If earnings and loan yields stabilize, multiple expansion is plausible.
*High operating margins and cash conversion*: An operating margin of ~59% and strong free cash flow can support dividends and modest buybacks without major equity dilution.
*Actionable management capital allocation*: Small buybacks and a predictable dividend show management is focused on returning cash to shareholders, which can help support the share price in a low-growth setup.
*Low correlation to market*: A very low beta (~0.11) and low volatility versus the market could make LOAN useful for investors looking for idiosyncratic, low-correlation income exposure inside small-cap credit equities.
Bear Case
*Funding stress or higher borrowing costs*: Because LOAN relies on credit facilities and notes, unfavorable refinancing terms or rate moves could compress margins or force asset sales at the wrong time. Recent facility amendments and past note redemptions highlight this vulnerability.
*Concentrated credit losses*: With a small portfolio, a handful of problem loans could materially hit earnings and capital.
*Limited analyst coverage / information asymmetry*: Light coverage and thin liquidity raise execution risk for investors and can exaggerate price moves on negative headlines.
*Low growth and valuation trap*: Cheap multiples can be a warning label, not a gift. If revenue growth stays around ~3–4%, the market may keep this stock on a discount multiple.
On Our Radar
*2026 Annual Meeting — June 18, 2026*: The company has indicated it will hold its annual shareholder meeting on June 18, 2026. Proxy items, director votes, and meeting outcomes can offer useful governance signals.
*Dividend record / payment dates (Q3 / July 2026 schedule)*: The company declared a quarterly dividend of $0.11 per share with a record/pay schedule in mid-2026 (announcements in April/May 2026). Those payments — and how comfortable they look versus cash flows — will be an important near-term read.
*Quarterly earnings / 10-Q (next release)*: The next quarterly filing should update originations, allowance for loan losses, interest income trends, and interest expense — three lines that most directly drive the earnings and leverage story. Watch the 10-Q for updated net debt, covenant language, and interest coverage.
*Any refinancing / credit-facility updates*: With past amendments and short-dated notes in the mix, any update on new facilities, amended terms, or redemptions can move the stock. It’s positive if maturities get extended on good terms, and negative if terms tighten.
Investment Conclusion
Manhattan Bridge Capital is a small, niche, asset-backed lender with modest growth, high operating margins, and very attractive headline cash metrics (a low forward P/E and a strong FCF yield). That combination can appeal to investors who want high free-cash-flow yield and low-correlation small-cap credit exposure, and who can live with concentrated credit risk and funding risk.
The trade-off is clear. LOAN runs above-average leverage versus the market (net debt/EBITDA ≈ 3.8), has limited scale, and is exposed to refinancing outcomes and borrower credit performance — all good reasons the market is pricing it at a discount.
Near-term upside catalysts include loan originations stabilizing or picking up, and refinancing funding lines on materially favorable terms. The downside catalysts are the mirror image: a funding squeeze, or unexpected loan losses.
A long-term, income-oriented investor could see LOAN as a selective, yield-style opportunity trading at a discount. A risk-averse investor may prefer alternatives with larger scale and deeper liquidity.
This report does not provide individualized investment advice. Investors should read the company’s 10-K/10-Q, monitor upcoming filings, and make sure their risk tolerance and position sizing fit before considering any investment.
| Help us improve Stock Snapshots — share your feedback.